Treatment of Insulin Resistance in Hypertensive, Obese Adolescents
NCT00185705
·
clinicaltrials.gov ↗
NA
Phase
TERMINATED
Status
30
Enrollment
OTHER
Sponsor class
Stopped
Primary investigator moved to different university
Conditions
Hypertension
Insulin Resistance
Dyslipidemia
Interventions
DRUG:
Telmisartan
Sponsor
Stanford University